143 related articles for article (PubMed ID: 19298719)
1. Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma.
Alacacioglu I; Ozcan MA; Ozkal S; Piskin O; Turgut N; Demirkan F; Ozsan GH; Kargi A; Undar B
Hematology; 2009 Apr; 14(2):84-9. PubMed ID: 19298719
[TBL] [Abstract][Full Text] [Related]
2. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
Ye ZY; Cao YB; Lin TY; Lin HL
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
Li M; Liu CL; Wang XY; Xue XM; Gao ZF
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):813-7. PubMed ID: 23324229
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].
Zeng LP; Wen YL; Ma Y; Wang GQ; Li Y; Wang J; Xu LL; Zhang XM
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):377-81. PubMed ID: 21914345
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Delabie J; Ott G; Müller-Hermelink HK; Campo E; Braziel RM; Jaffe ES; Pan Z; Farinha P; Smith LM; Falini B; Banham AH; Rosenwald A; Staudt LM; Connors JM; Armitage JO; Chan WC
Blood; 2004 Jan; 103(1):275-82. PubMed ID: 14504078
[TBL] [Abstract][Full Text] [Related]
6. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
7. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
8. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation.
Song Y; Cao Z; Li L; Zhang HT; Zhang X
Chin J Cancer; 2010 Sep; 29(9):781-6. PubMed ID: 20800019
[TBL] [Abstract][Full Text] [Related]
9. [Detection of t (14; 18) translocation and bcl-2 amplification in diffuse large B-cell lymphoma].
Jiang HY; Li HL; Hu H; He Y; Zhao T
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):84-9. PubMed ID: 17493380
[TBL] [Abstract][Full Text] [Related]
10. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
De Paepe P; Achten R; Verhoef G; Wlodarska I; Stul M; Vanhentenrijk V; Praet M; De Wolf-Peeters C
J Clin Oncol; 2005 Oct; 23(28):7060-8. PubMed ID: 16129841
[TBL] [Abstract][Full Text] [Related]
11. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma].
Wen JJ; Liu ZB; Xu J; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1004-9. PubMed ID: 23363791
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two different immunohistochemical algorithms identifying prognostic subgroups of DLBCL.
Jabłońska J; Jesionek-Kupnicka D; Potemski P; Kowalik A; Sygut J; Kordek R
Pol J Pathol; 2010; 61(3):124-32. PubMed ID: 21225494
[TBL] [Abstract][Full Text] [Related]
13. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
Cao QW; Li HY; Yao XX; Wang JF
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia.
Peh SC; Gan GG; Lee LK; Eow GI
Pathol Int; 2008 Sep; 58(9):572-9. PubMed ID: 18801072
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification.
Kim YR; Kim SJ; Cheong JW; Kim Y; Jang JE; Lee JY; Min YH; Song JW; Yang WI; Kim JS
Ann Hematol; 2014 Nov; 93(11):1867-77. PubMed ID: 24947797
[TBL] [Abstract][Full Text] [Related]
16. Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry.
Hirose Y; Masaki Y; Karasawa H; Shimoyama K; Fukushima T; Kawabata H; Ogawa N; Wano Y; Ozaki M
Int J Hematol; 2005 Jan; 81(1):48-57. PubMed ID: 15717689
[TBL] [Abstract][Full Text] [Related]
17. [Significance of CD138 in immunohistochemical profiles and its correlation with prognosis in diffuse large B-cell lymphoma].
Zhang HW; Chen ZW; Wang JF; Cheng NL
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):115-20. PubMed ID: 21575479
[TBL] [Abstract][Full Text] [Related]
18. [State of chromosome 3q27 and different subtypes of diffuse large B-cell lymphoma and their prognostic correlation].
Li Y; Wang GP; Xi YF; Wang JF; Bai W
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):231-6. PubMed ID: 19575893
[TBL] [Abstract][Full Text] [Related]
19. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
Costa LJ; Feldman AL; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM
Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]